Ganetespib potentiates the anti-cancer effects of lapatinib in ErbB2+ breast cancer cells. Ganetespib is under investigation for the treatment of Small Cell Lung Cancer, Acute Myeloid Leukaemia, and Myelodysplastic Syndrome. Reference standards of Ganetespib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Ganetespib - API Standards [catalogue_number] => PA 07 49000 [category_ids] => ,78,70,82, [chemical_name] => [weight] => 364.30 [form] => C20H20N4O3 [cas] => 888216-25-9 [pslug] => 888216-25-9-ganetespib-api-pa0749000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 07 49000
CAS :
Molecular Formula : C20H20N4O3
Molecular Weight : 364.30
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....